Multicentric pilot study to standardize clinical whole exome sequencing (WES) for cancer patients

被引:17
|
作者
Menzel, Michael [1 ,2 ]
Ossowski, Stephan [3 ,4 ,5 ]
Kral, Sebastian [6 ,7 ]
Metzger, Patrick [7 ,8 ]
Horak, Peter [2 ,9 ,10 ]
Marienfeld, Ralf [11 ,12 ]
Boerries, Melanie [7 ,8 ,13 ,14 ]
Wolter, Steffen [6 ,7 ]
Ball, Markus [1 ,2 ]
Neumann, Olaf [1 ,2 ]
Armeanu-Ebinger, Sorin [3 ,4 ]
Schroeder, Christopher [3 ,4 ]
Matysiak, Uta [6 ,7 ]
Goldschmid, Hannah [1 ,2 ]
Schipperges, Vincent [7 ,8 ]
Fuerstberger, Axel [11 ,12 ,15 ]
Allgaeuer, Michael [1 ,2 ]
Eberhardt, Timo [11 ,12 ]
Niewoehner, Jakob [11 ]
Blaumeiser, Andreas [7 ,8 ,14 ]
Ploeger, Carolin [1 ,2 ]
Haack, Tobias Bernd [3 ,4 ]
Tay, Timothy Kwang Yong [1 ,2 ,16 ]
Kelemen, Olga [3 ,4 ]
Pauli, Thomas [7 ,8 ]
Kirchner, Martina [1 ,2 ]
Kluck, Klaus [1 ,2 ]
Ott, Alexander [3 ,4 ]
Renner, Marcus [1 ,2 ,9 ]
Admard, Jakob [3 ,4 ]
Gschwind, Axel [3 ,4 ]
Lassmann, Silke [6 ,7 ]
Kestler, Hans [11 ,12 ]
Fend, Falko [17 ]
Illert, Anna Lena [18 ,19 ,20 ]
Werner, Martin [6 ,7 ,14 ]
Moeller, Peter [11 ]
Seufferlein, Thomas Theodor Werner [12 ,21 ]
Malek, Nisar [4 ,22 ]
Schirmacher, Peter [1 ,2 ,10 ]
Froehling, Stefan [2 ,9 ,10 ]
Kazdal, Daniel [1 ,2 ]
Budczies, Jan [1 ,2 ,10 ]
Stenzinger, Albrecht [1 ,2 ,10 ]
机构
[1] Heidelberg Univ Hosp, Inst Pathol, Heidelberg, Germany
[2] Ctr Personalized Med ZPM, Heidelberg, Germany
[3] Univ Tubingen, Inst Med Genet & Appl Genom, Tubingen, Germany
[4] Ctr Personalized Med ZPM, Tubingen, Germany
[5] Univ Tubingen, Inst Bioinformat & Med Informat IBMI, Tubingen, Germany
[6] Univ Freiburg, Inst Surg Pathol, Med Ctr, Freiburg, Germany
[7] Ctr Personalized Med ZPM, Freiburg, Germany
[8] Univ Freiburg, Freiburg Univ Med Ctr, Inst Med Bioinformat & Syst Med IBSM, Fac Med, Freiburg, Germany
[9] Heidelberg & German Canc Res Ctr DKFZ, Natl Ctr Tumor Dis NCT, Div Translat Med Oncol, D-69120 Heidelberg, Germany
[10] German Canc Consortium DKTK, Heidelberg, Germany
[11] Univ Hosp Ulm, Inst Pathol, Ulm, Germany
[12] Ctr Personalized Med ZPM, Ulm, Germany
[13] Univ Freiburg, Fac Med, Comprehens Canc Ctr Freiburg CCCF, Med Ctr, Freiburg, Germany
[14] German Canc Consortium DKTK, German Canc Res Ctr DKFZ, Partner Site Freiburg, Heidelberg, Germany
[15] Ulm Univ, Inst Med Syst Biol, Ulm, Germany
[16] Singapore Gen Hosp, Dept Anat Pathol, Singapore, Singapore
[17] Univ Hosp Tubingen, Inst Pathol & Neuropathol, Tubingen, Germany
[18] Univ Freiburg, Fac Med, Med Ctr, Dept Radiol,Med Phys, D-79085 Freiburg, Germany
[19] Tech Univ Munich, Klinikum Rechts Isar, Nukl Med Klin & Poliklin, D-81675 Munich, Germany
[20] German Canc Consortium DKTK, Partner Site Munich & German Canc Res Ctr DKFZ, Heidelberg, Germany
[21] Univ Hosp Ulm, Dept Internal Medicine1, Ulm, Germany
[22] Univ Hosp Tubingen, Dept Internal Med, Tubingen, Germany
关键词
COPY NUMBER; PERSONALIZED MEDICINE; TUMOR; GENOMICS; ONCOLOGY;
D O I
10.1038/s41698-023-00457-x
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
A growing number of druggable targets and national initiatives for precision oncology necessitate broad genomic profiling for many cancer patients. Whole exome sequencing (WES) offers unbiased analysis of the entire coding sequence, segmentation-based detection of copy number alterations (CNAs), and accurate determination of complex biomarkers including tumor mutational burden (TMB), homologous recombination repair deficiency (HRD), and microsatellite instability (MSI). To assess the inter-institution variability of clinical WES, we performed a comparative pilot study between German Centers of Personalized Medicine (ZPMs) from five participating institutions. Tumor and matched normal DNA from 30 patients were analyzed using custom sequencing protocols and bioinformatic pipelines. Calling of somatic variants was highly concordant with a positive percentage agreement (PPA) between 91 and 95% and a positive predictive value (PPV) between 82 and 95% compared with a three-institution consensus and full agreement for 16 of 17 druggable targets. Explanations for deviations included low VAF or coverage, differing annotations, and different filter protocols. CNAs showed overall agreement in 76% for the genomic sequence with high wet-lab variability. Complex biomarkers correlated strongly between institutions (HRD: 0.79-1, TMB: 0.97-0.99) and all institutions agreed on microsatellite instability. This study will contribute to the development of quality control frameworks for comprehensive genomic profiling and sheds light onto parameters that require stringent standardization.
引用
收藏
页数:11
相关论文
共 50 条
  • [21] Successful whole-exome sequencing from a prostate cancer bone metastasis biopsy
    E M Van Allen
    A Foye
    N Wagle
    W Kim
    S L Carter
    A McKenna
    J P Simko
    L A Garraway
    P G Febbo
    Prostate Cancer and Prostatic Diseases, 2014, 17 : 23 - 27
  • [22] Successful whole-exome sequencing from a prostate cancer bone metastasis biopsy
    Van Allen, E. M.
    Foye, A.
    Wagle, N.
    Kim, W.
    Carter, S. L.
    McKenna, A.
    Simko, J. P.
    Garraway, L. A.
    Febbo, P. G.
    PROSTATE CANCER AND PROSTATIC DISEASES, 2014, 17 (01) : 23 - 27
  • [23] Mutational burden of resectable pancreatic cancer, as determined by whole transcriptome and whole exome sequencing, predicts a poor prognosis
    Grassi, Elisa
    Durante, Sandra
    Astolfi, Annalisa
    Tarantino, Giuseppe
    Indio, Valentina
    Freier, Eva
    Vecchiarelli, Silvia
    Ricci, Claudio
    Casadei, Riccardo
    Formica, Francesca
    Filippini, Daria
    Comito, Francesca
    Serra, Carla
    Santini, Donatella
    Errico, Antonietta D'
    Minni, Francesco
    Biasco, Guido
    Di Marco, Mariacristina
    INTERNATIONAL JOURNAL OF ONCOLOGY, 2018, 52 (06) : 1972 - 1980
  • [24] Clinical Validation of Whole Genome Sequencing for Cancer Diagnostics
    Roepman, Paul
    de Bruijn, Ewart
    van Lieshout, Stef
    Schoenmaker, Lieke
    Boelens, Mirjam C.
    Dubbink, Hendrikus J.
    Geurts-Giele, Willemina R. R.
    Groenendijk, Floris H.
    Huibers, Manon M. H.
    Kranendonk, Mariette E. G.
    Roemer, Margaretha G. M.
    Samsom, Kris G.
    Steehouwer, Marloes
    de Leng, Wendy W. J.
    Hoischen, Alexander
    Ylstra, Bauke
    Monkhorst, Kim
    van der Hoeven, Jacobus J. M.
    Cuppen, Edwin
    JOURNAL OF MOLECULAR DIAGNOSTICS, 2021, 23 (07) : 816 - 833
  • [25] Trio-based whole-exome sequencing of 200 Chinese patients with keratoconus
    Li, Xingyong
    Yao, Yinghao
    Xing, Shilai
    Zheng, Yi-Han
    Zhou, Yang
    Yu, Xiaoguang
    Su, Jianzhong
    Chen, Shihao
    Jin, Zi-Bing
    EXPERIMENTAL EYE RESEARCH, 2024, 248
  • [26] Genetic diagnosis of autoinflammatory disease patients using clinical exome sequencing
    Batlle-Maso, Laura
    Mensa-Vilaro, Anna
    Solis-Moruno, Manuel
    Marques-Bonet, Tomas
    Arostegui, Juan I.
    Casals, Ferran
    EUROPEAN JOURNAL OF MEDICAL GENETICS, 2020, 63 (05)
  • [27] Toward Precision Oncology in Glioblastoma with a Personalized Cancer Genome Reporting Tool and Genetic Changes Identified by Whole Exome Sequencing
    Erdogan, Onur
    Ozkaya, Seyma Colakoglu
    Erzik, Can
    Bilguvar, Kaya
    Arga, Kazim Yalcin
    Bayrakli, Fatih
    OMICS-A JOURNAL OF INTEGRATIVE BIOLOGY, 2023, 27 (09) : 426 - 433
  • [28] Whole exome sequencing in molecular diagnostics of cancer decreases over time: evidence from a cost analysis in the French setting
    Bayle, Arnaud
    Droin, N.
    Besse, B.
    Zou, Z.
    Boursin, Y.
    Rissel, S.
    Solary, E.
    Lacroix, L.
    Rouleau, E.
    Borget, I.
    Bonastre, J.
    EUROPEAN JOURNAL OF HEALTH ECONOMICS, 2021, 22 (06) : 855 - 864
  • [29] Whole exome sequencing in molecular diagnostics of cancer decreases over time: evidence from a cost analysis in the French setting
    Arnaud Bayle
    N. Droin
    B. Besse
    Z. Zou
    Y. Boursin
    S. Rissel
    E. Solary
    L. Lacroix
    E. Rouleau
    I. Borget
    J. Bonastre
    The European Journal of Health Economics, 2021, 22 : 855 - 864
  • [30] Mutational landscape of 3000 cancer tissues with whole exome sequencing and panel-based deep sequencing - Project HOPE
    Nagashima, Takeshi
    Shimoda, Yuji
    Tanabe, Tomoe
    Saito, Junko
    Yoshioka, Junichi
    Kamada, Fukumi
    Ohshima, Keiichi
    Urakami, Kenichi
    Ohnami, Sumiko
    Ohnami, Shumpei
    Mochizuki, Tohru
    Kusuhara, Masatoshi
    Yamaguchi, Ken
    CANCER SCIENCE, 2018, 109 : 990 - 990